By including multiple replicates and doses per drug, we discover high-confidence drug-responsive chromatin regions and genes. We show that EZH2 degradation via MS177 coincides with up-regulation of NF-kB signaling, and SWI/SNF perturbation elicits a potent type I interferon response.
